查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1339231

基因组学市场中的人工智慧.份额.规模.趋势.行业分析报告:按产品提供.技术.功能.应用.最终用户.地区和细分市场的预测2023-2032 年

AI in Genomics Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Functionality, By Application, By End User, By Region, Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的一项新研究，到2032年，基因组学领域人工智慧的全球市场规模预计将达到167.5795亿美元。该报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

产生基因组数据所需的大量财务支持在推动市场成长方面发挥关键作用。国家人类基因组研究所 (NHGRI) 等机构每年分配超过 1.25 亿美元的大量资金来支持各种基因组数据科学计划，为这一增长做出了重大贡献。这种财政支持使研究人员和组织能够创建和累积大量基因组数据集。随着基因组数据量的增加，对人工智慧技术（包括机器学习和深度学习演算法）的需求不断增长，以有效分析大量资讯并从中获取见解。

私有云和商业云之间透过 STRIDES 等措施以及美国国立卫生研究院 (NIH) 等政府和公共机构之间的合作正在推动市场成长。这些联合计划将支援储存和运算基础设施来託管基因组数据。这些措施提供了一个可扩展且安全的平台，用于处理基因组研究中产生的大量基因组数据。此外，这些公司优先考虑实施强有力的安全和隐私措施，以保护敏感的人类基因组资料。

基因组学市场中的人工智慧报告亮点

由于基因组数据的增加，预计软体产业在未来几年将成长更快。

由于资料量和复杂性不断增加，机器学习领域占据了最大的收入份额。

由于 DNA 定序技术的进步，基因组定序领域预计将占据最大的收入份额。

由于个人化治疗方法的增加，精准医学预计将出现强劲的成长。

由于药物发现的加速，製药和生物技术公司预计将显着成长。

由于政府不断采取措施促进医疗保健，预计北美将占据最大的收入份额。另一方面，欧洲将透过资助计画获得政府的推动，预计将获得更大的收入份额。

目录

第 1 章 简介

第二章执行摘要

第三章研究方法论

第 4 章：基因组学领域的全球人工智慧市场洞察

  • 基因组学中的人工智慧 - 产业快照
  • 基因组学领域的人工智慧市场动态
    • 驱动因素和机遇
      • 生物医学研究计画快速成长
      • 技术进步与运算能力
    • 限制因素和挑战
      • 数据品质和可用性
  • PESTLE分析
  • 基因组学产业的人工智慧趋势
  • COVID-19 感染的影响分析

第五章基因组学领域的全球人工智慧市场，透过提供

  • 主要发现
  • 介绍
  • 软件
  • 服务

第六章 全球基因体学人工智慧市场（按技术）

  • 主要发现
  • 介绍
  • 机器学习
  • 其他技术

第七章 全球基因体学人工智慧市场（按功能）

  • 主要发现
  • 介绍
  • 基因组测序
  • 基因编辑
  • 临床工作流程
  • 预测基因检测与预防医学

第八章全球基因组学人工智慧市场（按应用）

  • 主要发现
  • 介绍
  • 诊断
  • 药物发现与开发
  • 精准医学
  • 农业和动物研究
  • 其他用途

第 9 章 全球基因组学人工智慧市场（按最终用户）

  • 主要发现
  • 介绍
  • 製药和生物技术公司
  • 保健提供者
  • 研究中心、学术机构、政府机构
  • 其他最终用户

第10章全球基因组学人工智慧市场（按地区）

  • 主要发现
  • 介绍
    • 基因组学人工智慧市场评估（按地区），2019-2032
  • 基因组学人工智慧市场 - 北美
    • 北美：2019-2032 年基因组学人工智慧市场（按产品分类）
    • 北美：基因组学人工智慧市场（按应用），2019-2032
    • 北美：基因组学人工智慧市场（按技术），2019-2032
    • 北美：基因组学人工智慧市场（按功能），2019-2032
    • 北美：基因组学人工智慧市场，按最终用户划分，2019-2032 年
    • 基因组学人工智慧市场 - 美国
    • 基因组学人工智慧市场 - 加拿大
  • 基因组学人工智慧市场 - 欧洲
    • 欧洲：基因组学人工智慧市场（按产品划分），2019-2032 年
    • 欧洲：基因组学人工智慧市场（按应用），2019-2032 年
    • 欧洲：基因组学人工智慧市场（按技术），2019-2032
    • 欧洲：基因组学人工智慧市场（按功能），2019-2032
    • 欧洲：基因组学人工智慧市场，按最终用户划分，2019-2032 年
    • 基因组学人工智慧市场 - 英国
    • 基因组学人工智慧市场 - 法国
    • 基因组学人工智慧市场 - 德国
    • 基因组学人工智慧市场 - 义大利
    • 基因组学人工智慧市场 - 西班牙
    • 基因组学人工智慧市场 - 荷兰
    • 基因组学人工智慧市场 - 俄罗斯
  • 基因组学人工智慧市场 - 亚太地区
    • 亚太地区：2019-2032 年基因体学人工智慧市场（依产品分类）
    • 亚太地区：基因组学人工智慧市场（按应用），2019-2032 年
    • 亚太地区：基因组学人工智慧市场（按技术），2019-2032 年
    • 亚太地区：基因组学人工智慧市场（按功能），2019-2032
    • 亚太地区：基因组学人工智慧市场，按最终用户划分，2019-2032 年
    • 基因组学人工智慧市场 - 中国
    • 基因组学人工智慧市场—印度
    • 基因组学领域的人工智慧市场——日本
    • 基因组学人工智慧市场 - 马来西亚
    • 基因组学人工智慧市场 - 印度尼西亚
    • 基因组学人工智慧市场—韩国
  • 基因组学人工智慧市场 - 中东和非洲
    • 中东和非洲：基因组市场中的人工智慧（按产品划分），2019-2032 年
    • 中东和非洲：基因组学人工智慧市场（按应用），2019-2032 年
    • 中东和非洲：基因组学人工智慧市场（按技术），2019-2032 年
    • 中东和非洲：基因组学人工智慧市场（按功能），2019-2032
    • 中东和非洲：基因组学人工智慧市场，按最终用户划分，2019-2032 年
    • 基因组学人工智慧市场 - 沙乌地阿拉伯
    • 基因组学人工智慧市场 - 阿联酋
    • 基因组学人工智慧市场 - 以色列
    • 基因组学人工智慧市场 - 南非
  • 基因组学人工智慧市场 - 拉丁美洲
    • 拉丁美洲：2019-2032 年基因组学人工智慧市场（按产品分类）
    • 拉丁美洲：基因组学人工智慧市场（按应用），2019-2032 年
    • 拉丁美洲：基因组学人工智慧市场（按技术），2019-2032 年
    • 拉丁美洲：基因组学人工智慧市场（按功能），2019-2032 年
    • 拉丁美洲：基因组学人工智慧市场，按最终用户划分，2019-2032 年
    • 基因组学人工智慧市场 - 墨西哥
    • 基因组学人工智慧市场 - 巴西
    • 基因组学人工智慧市场 - 阿根廷

第十一章竞争格局

  • 扩张和收购分析
    • 扩张
    • 获得
  • 伙伴关係/协作/协议/揭露

第十二章公司简介

  • Google DeepMind
  • IBM Watson Health
  • BenevolentAI
  • Tempus
  • Freenome
  • Sophia Genetics
  • 23andMe
  • DNAnexus
  • Recursion Pharmaceuticals
  • Verge Genomics
  • PathAI
  • GNS Healthcare
  • Freenome
  • Fabric Genomics
  • Foundation Medicine
  • SOPHiA GENETICS
  • Nebula Genomics
  • CytoReason
  • Genoox
  • Genalice
  • Deep Genomics
  • Owkin
  • Genialis
  • Gencove
  • Helix
  • QIAGEN Bioinformatics
  • SOPHiA DDM
  • WuXi NextCODE
  • Genuity Science
  • Lifebit
  • Envisagenics
  • ZS Genetics
  • MedGenome
  • Cypher Genomics
  • PierianDx
  • Bluebee
  • Repositive
  • Precision for Medicine
  • Shivom
  • Bluegnome
Product Code: PM3611

The global AI in genomics market size is expected to reach USD 16,757.95 million by 2032, according to a new study by Polaris Market Research. The report "AI in Genomics Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Functionality, By Application, By End User, By Region, Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The substantial financial support required to generate genomic data plays a crucial role in driving the market's growth. Institutions like the National Human Genome Research Institute (NHGRI) contribute significantly to this growth by allocating substantial funding, with an annual investment of over $125 million, to support diverse genomic data science initiatives. This financial backing enables researchers and organizations to generate and accumulate extensive genomic datasets. As the volume of genomic data increases, the demand for AI technologies, including machine learning and deep learning algorithms, rises to effectively analyze and derive insights from this vast amount of information.

The collaboration between private & commercial cloud and governmental & public entities, such as the National Institutes of Health (NIH) through initiatives like STRIDES, drives the market's growth. These collaborative initiatives support the storage and computing infrastructure to host genomic data. They provide scalable and secure platforms to handle the large volumes of genomic data generated in genomics research. Additionally, they prioritize implementing robust security and privacy measures to safeguard sensitive human genomic data.

AI in Genomics Market Report Highlights

Software segment is anticipated to witness faster growth in the coming years due to the rise in genomic data.

Machine Learning segment accounted for the largest revenue share owing to the increased volume and complexity of data.

Genome Sequencing segment is projected to experience the largest revenue share due to the advancements in DNA sequencing technologies.

Precision Medicine is expected to witness significant growth rate due to growing personalized treatment approaches.

Pharmaceuticals and Biotech Companies are expected to grow at a substantial rate due to accelerated drug discovery.

North America is projected to witness largest revenue share owing to the rise in government initiatives to promote healthcare. While Europe is expected to grow a larger revenue share owing to the encouragement from the governments by funding the projects.

The global players include: Google DeepMind, QIAGEN Bioinformatics, SOPHiA DDM, WuXi NextCODE, Genuity Science, Lifebit, Envisagenics, ZS Genetics, MedGenome, Cypher Genomics, PierianDx, Bluebee, Repositive, Precision for Medicine, Shivom & Bluegnome.

Polaris Market Research has segmented the AI in Genomics market report based on offering, technology, functionality, application, end user and region:

AI in Genomics, Offering Outlook (Revenue - USD Million, 2019 - 2032)

  • Software
  • Services

AI in Genomics, Technology Outlook (Revenue - USD Million, 2019 - 2032)

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Unsupervised Learning
  • Reinforcement Learning
  • Other Machine Learning Technologies
  • Other Technologies

AI in Genomics, Functionality Outlook (Revenue - USD Million, 2019 - 2032)

  • Genome Sequencing
  • Gene Editing
  • Clinical Workflows
  • Predictive Genetic Testing & Preventive Medicine

AI in Genomics, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Diagnostics
  • Drug Discovery & Development
  • Precision Medicine
  • Agriculture & Animal Research
  • Other Applications

AI in Genomics, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical and Biotech Companies
  • Healthcare Providers
  • Research Centres, Academic Institutes and Government Organization
  • Other End Users

AI in Genomics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global AI in Genomics Market Insights

  • 4.1. AI in Genomics - Industry Snapshot
  • 4.2. AI in Genomics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Exponential growth of biomedical research projects
      • 4.2.1.2. Technological advancements and computational power
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data quality and availability
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. AI in Genomics Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global AI in Genomics Market, by Offering

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • 5.3. Software
    • 5.3.1. Global AI in Genomics Market, by Software, by Region, 2019-2032 (USD Million)
  • 5.4. Services
    • 5.4.1. Global AI in Genomics Market, by Services, by Region, 2019-2032 (USD Million)

6. Global AI in Genomics Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • 6.3. Machine Learning
    • 6.3.1. Global AI in Genomics Market, by Machine Learning, by Region, 2019-2032 (USD Million)
    • 6.3.2. Deep Learning
      • 6.3.2.1. Global AI in Genomics Market, by Deep Learning, by Region, 2019-2032 (USD Million)
    • 6.3.3. Supervised Learning
      • 6.3.3.1. Global AI in Genomics Market, by Supervised Learning, by Region, 2019-2032 (USD Million)
    • 6.3.4. Unsupervised Learning
      • 6.3.4.1. Global AI in Genomics Market, by Unsupervised Learning, by Region, 2019-2032 (USD Million)
    • 6.3.5. Reinforcement Learning
      • 6.3.5.1. Global AI in Genomics Market, by Reinforcement Learning, by Region, 2019-2032 (USD Million)
    • 6.3.6. Other Machine Learning Technologies
      • 6.3.6.1. Global AI in Genomics Market, by Other Machine Learning Technologies, by Region, 2019-2032 (USD Million)
  • 6.4. Others Technologies
    • 6.4.1. Global AI in Genomics Market, by Others Technologies, by Region, 2019-2032 (USD Million)

7. Global AI in Genomics Market, by Functionality

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • 7.3. Genome Sequencing
    • 7.3.1. Global AI in Genomics Market, by Genome Sequencing, by Region, 2019-2032 (USD Million)
  • 7.4. Gene Editing
    • 7.4.1. Global AI in Genomics Market, by Gene Editing, by Region, 2019-2032 (USD Million)
  • 7.5. Clinical Workflows
    • 7.5.1. Global AI in Genomics Market, by Clinical Workflows, by Region, 2019-2032 (USD Million)
  • 7.6. Predictive Genetic Testing & Preventive Medicine
    • 7.6.1. Global AI in Genomics Market, by Predictive Genetic Testing & Preventive Medicine, by Region, 2019-2032 (USD Million)

8. Global AI in Genomics Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • 8.3. Diagnostics
    • 8.3.1. Global AI in Genomics Market, by Diagnostics, by Region, 2019-2032 (USD Million)
  • 8.4. Drug Discovery & Development
    • 8.4.1. Global AI in Genomics Market, by Drug Discovery & Development, by Region, 2019-2032 (USD Million)
  • 8.5. Precision Medicine
    • 8.5.1. Global AI in Genomics Market, by Precision Medicine, by Region, 2019-2032 (USD Million)
  • 8.6. Agriculture & Animal Research
    • 8.6.1. Global AI in Genomics Market, by Agriculture & Animal Research, by Region, 2019-2032 (USD Million)
  • 8.7. Other Applications
    • 8.7.1. Global AI in Genomics Market, by Other Applications, by Region, 2019-2032 (USD Million)

9. Global AI in Genomics Market, by End User

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 9.3. Pharmaceutical and Biotech Companies
    • 9.3.1. Global AI in Genomics Market, by Pharmaceutical and Biotech Companies, by Region, 2019-2032 (USD Million)
  • 9.4. Healthcare Providers
    • 9.4.1. Global AI in Genomics Market, by Healthcare Providers, by Region, 2019-2032 (USD Million)
  • 9.5. Research Centres, Academic Institutes and Government Organization
    • 9.5.1. Global AI in Genomics Market, by Research Centres, Academic Institutes and Government Organization, by Region, 2019-2032 (USD Million)
  • 9.6. Other End Users
    • 9.6.1. Global AI in Genomics Market, by Other End Users, by Region, 2019-2032 (USD Million)

10. Global AI in Genomics Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. AI in Genomics Market Assessment, By Geography, 2019-2032 (USD Million)
  • 10.3. AI in Genomics Market - North America
    • 10.3.1. North America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.3.2. North America: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.3.3. North America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.3.4. North America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.3.5. North America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.3.6. AI in Genomics Market - U.S.
      • 10.3.6.1. U.S.: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.3.6.2. U.S.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.3.6.3. U.S.: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.3.6.4. U.S.: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.3.6.5. U.S.: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.3.7. AI in Genomics Market - Canada
      • 10.3.7.1. Canada: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.3.7.2. Canada.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.3.7.3. Canada: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.3.7.4. Canada: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.3.7.5. Canada: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 10.4. AI in Genomics Market - Europe
    • 10.4.1. Europe: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.4.2. Europe.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.4.3. Europe: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.4.4. Europe: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.4.5. Europe: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.6. AI in Genomics Market - UK
      • 10.4.6.1. UK: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.6.2. UK.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.6.3. UK: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.6.4. UK: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.6.5. UK: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.7. AI in Genomics Market - France
      • 10.4.7.1. France: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.7.2. France.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.7.3. France: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.7.4. France: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.7.5. France: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.8. AI in Genomics Market - Germany
      • 10.4.8.1. Germany: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.8.2. Germany.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.8.3. Germany: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.8.4. Germany: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.8.5. Germany: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.9. AI in Genomics Market - Italy
      • 10.4.9.1. Italy: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.9.2. Italy.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.9.3. Italy: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.9.4. Italy: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.9.5. Italy: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.10. AI in Genomics Market - Spain
      • 10.4.10.1. Spain: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.10.2. Spain.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.10.3. Spain: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.10.4. Spain: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.10.5. Spain: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.11. AI in Genomics Market - Netherlands
      • 10.4.11.1. Netherlands: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.11.2. Netherlands.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.11.3. Netherlands: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.11.4. Netherlands: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.11.5. Netherlands: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.12. AI in Genomics Market - Russia
      • 10.4.12.1. Russia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.12.2. Russia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.12.3. Russia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.12.4. Russia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.12.5. Russia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 10.5. AI in Genomics Market - Asia Pacific
    • 10.5.1. Asia Pacific: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.5.2. Asia Pacific.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.5.3. Asia Pacific: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.5.4. Asia Pacific: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.5.5. Asia Pacific: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.6. AI in Genomics Market - China
      • 10.5.6.1. China: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.6.2. China.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.6.3. China: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.6.4. China: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.6.5. China: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.7. AI in Genomics Market - India
      • 10.5.7.1. India: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.7.2. India.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.7.3. India: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.7.4. India: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.7.5. India: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.8. AI in Genomics Market - Japan
      • 10.5.8.1. Japan: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.8.2. Japan.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.8.3. Japan: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.8.4. Japan: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.8.5. Japan: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.9. AI in Genomics Market - Malaysia
      • 10.5.9.1. Malaysia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.9.2. Malaysia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.9.3. Malaysia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.9.4. Malaysia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.9.5. Malaysia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.10. AI in Genomics Market - Indonesia
      • 10.5.10.1. Indonesia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.10.2. Indonesia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.10.3. Indonesia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.10.4. Indonesia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.10.5. Indonesia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.11. AI in Genomics Market - South Korea
      • 10.5.11.1. South Korea: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.11.2. South Korea.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.11.3. South Korea: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.11.4. South Korea: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.11.5. South Korea: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 10.6. AI in Genomics Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.6.2. Middle East & Africa: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.6.3. Middle East & Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.6.4. Middle East & Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.6.5. Middle East & Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.6.6. AI in Genomics Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.6.6.2. Saudi Arabia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.6.6.3. Saudi Arabia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.6.4. Saudi Arabia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.6.6.5. Saudi Arabia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.6.7. AI in Genomics Market - UAE
      • 10.6.7.1. UAE: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.6.7.2. UAE.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.6.7.3. UAE: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.7.4. UAE: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.6.7.5. UAE: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.6.8. AI in Genomics Market - Israel
      • 10.6.8.1. Israel: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.6.8.2. Israel.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.6.8.3. Israel: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.8.4. Israel: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.6.8.5. Israel: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.6.9. AI in Genomics Market - South Africa
      • 10.6.9.1. South Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.6.9.2. South Africa.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.6.9.3. South Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.9.4. South Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.6.9.5. South Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 10.7. AI in Genomics Market - Latin America
    • 10.7.1. Latin America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.7.2. Latin America.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.7.3. Latin America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.7.4. Latin America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.7.5. Latin America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.7.6. AI in Genomics Market - Mexico
      • 10.7.6.1. Mexico: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.7.6.2. Mexico.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.7.6.3. Mexico: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.7.6.4. Mexico: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.7.6.5. Mexico: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.7.7. AI in Genomics Market - Brazil
      • 10.7.7.1. Brazil: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.7.7.2. Brazil.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.7.7.3. Brazil: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.7.7.4. Brazil: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.7.7.5. Brazil: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.7.8. AI in Genomics Market - Argentina
      • 10.7.8.1. Argentina: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.7.8.2. Argentina.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.7.8.3. Argentina: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.7.8.4. Argentina: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.7.8.5. Argentina: AI in Genomics Market, by End User, 2019-2032 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Google DeepMind
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. IBM Watson Health
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. BenevolentAI
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Tempus
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Freenome
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Sophia Genetics
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. 23andMe
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. DNAnexus
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Recursion Pharmaceuticals
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Verge Genomics
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. PathAI
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. GNS Healthcare
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development
  • 12.13. Freenome
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Benchmarking
    • 12.13.4. Recent Development
  • 12.14. Fabric Genomics
    • 12.14.1. Company Overview
    • 12.14.2. Financial Performance
    • 12.14.3. Product Benchmarking
    • 12.14.4. Recent Development
  • 12.15. Foundation Medicine
    • 12.15.1. Company Overview
    • 12.15.2. Financial Performance
    • 12.15.3. Product Benchmarking
    • 12.15.4. Recent Development
  • 12.16. SOPHiA GENETICS
    • 12.16.1. Company Overview
    • 12.16.2. Financial Performance
    • 12.16.3. Product Benchmarking
    • 12.16.4. Recent Development
  • 12.17. Nebula Genomics
    • 12.17.1. Company Overview
    • 12.17.2. Financial Performance
    • 12.17.3. Product Benchmarking
    • 12.17.4. Recent Development
  • 12.18. CytoReason
    • 12.18.1. Company Overview
    • 12.18.2. Financial Performance
    • 12.18.3. Product Benchmarking
    • 12.18.4. Recent Development
  • 12.19. Genoox
    • 12.19.1. Company Overview
    • 12.19.2. Financial Performance
    • 12.19.3. Product Benchmarking
    • 12.19.4. Recent Development
  • 12.20. Genalice
    • 12.20.1. Company Overview
    • 12.20.2. Financial Performance
    • 12.20.3. Product Benchmarking
    • 12.20.4. Recent Development
  • 12.21. Deep Genomics
    • 12.21.1. Company Overview
    • 12.21.2. Financial Performance
    • 12.21.3. Product Benchmarking
    • 12.21.4. Recent Development
  • 12.22. Owkin
    • 12.22.1. Company Overview
    • 12.22.2. Financial Performance
    • 12.22.3. Product Benchmarking
    • 12.22.4. Recent Development
  • 12.23. Genialis
    • 12.23.1. Company Overview
    • 12.23.2. Financial Performance
    • 12.23.3. Product Benchmarking
    • 12.23.4. Recent Development
  • 12.24. Gencove
    • 12.24.1. Company Overview
    • 12.24.2. Financial Performance
    • 12.24.3. Product Benchmarking
    • 12.24.4. Recent Development
  • 12.25. Helix
    • 12.25.1. Company Overview
    • 12.25.2. Financial Performance
    • 12.25.3. Product Benchmarking
    • 12.25.4. Recent Development
  • 12.26. QIAGEN Bioinformatics
    • 12.26.1. Company Overview
    • 12.26.2. Financial Performance
    • 12.26.3. Product Benchmarking
    • 12.26.4. Recent Development
  • 12.27. SOPHiA DDM
    • 12.27.1. Company Overview
    • 12.27.2. Financial Performance
    • 12.27.3. Product Benchmarking
    • 12.27.4. Recent Development
  • 12.28. WuXi NextCODE
    • 12.28.1. Company Overview
    • 12.28.2. Financial Performance
    • 12.28.3. Product Benchmarking
    • 12.28.4. Recent Development
  • 12.29. Genuity Science
    • 12.29.1. Company Overview
    • 12.29.2. Financial Performance
    • 12.29.3. Product Benchmarking
    • 12.29.4. Recent Development
  • 12.30. Lifebit
    • 12.30.1. Company Overview
    • 12.30.2. Financial Performance
    • 12.30.3. Product Benchmarking
    • 12.30.4. Recent Development
  • 12.31. Envisagenics
    • 12.31.1. Company Overview
    • 12.31.2. Financial Performance
    • 12.31.3. Product Benchmarking
    • 12.31.4. Recent Development
  • 12.32. ZS Genetics
    • 12.32.1. Company Overview
    • 12.32.2. Financial Performance
    • 12.32.3. Product Benchmarking
    • 12.32.4. Recent Development
  • 12.33. MedGenome
    • 12.33.1. Company Overview
    • 12.33.2. Financial Performance
    • 12.33.3. Product Benchmarking
    • 12.33.4. Recent Development
  • 12.34. Cypher Genomics
    • 12.34.1. Company Overview
    • 12.34.2. Financial Performance
    • 12.34.3. Product Benchmarking
    • 12.34.4. Recent Development
  • 12.35. PierianDx
    • 12.35.1. Company Overview
    • 12.35.2. Financial Performance
    • 12.35.3. Product Benchmarking
    • 12.35.4. Recent Development
  • 12.36. Bluebee
    • 12.36.1. Company Overview
    • 12.36.2. Financial Performance
    • 12.36.3. Product Benchmarking
    • 12.36.4. Recent Development
  • 12.37. Repositive
    • 12.37.1. Company Overview
    • 12.37.2. Financial Performance
    • 12.37.3. Product Benchmarking
    • 12.37.4. Recent Development
  • 12.38. Precision for Medicine
    • 12.38.1. Company Overview
    • 12.38.2. Financial Performance
    • 12.38.3. Product Benchmarking
    • 12.38.4. Recent Development
  • 12.39. Shivom
    • 12.39.1. Company Overview
    • 12.39.2. Financial Performance
    • 12.39.3. Product Benchmarking
    • 12.39.4. Recent Development
  • 12.40. Bluegnome
    • 12.40.1. Company Overview
    • 12.40.2. Financial Performance
    • 12.40.3. Product Benchmarking
    • 12.40.4. Recent Development

List of Tables

  • Table 1 Global AI in Genomics Market, by Offering, by Region, 2019-2032 (USD Million)
  • Table 2 Global AI in Genomics Market, by Technology, by Region, 2019-2032 (USD Million)
  • Table 3 Global AI in Genomics Market, by Functionality, by Region, 2019-2032 (USD Million)
  • Table 4 Global AI in Genomics Market, by End User, by Region, 2019-2032 (USD Million)
  • Table 5 Global AI in Genomics Market, by Application, by Region, 2019-2032 (USD Million)
  • Table 6 North America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 7 North America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 8 North America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 9 North America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 10 North America: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 11 U.S.: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 12 U.S.: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 13 U.S.: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 14 U.S.: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 15 U.S.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 16 Canada: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 17 Canada: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 18 Canada: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 19 Canada: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 20 Canada: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 21 Europe: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 22 Europe: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 23 Europe: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 24 Europe: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 25 Europe: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 26 Germany: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 27 Germany: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 28 Germany: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 29 Germany: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 30 Germany: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 31 France: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 32 France: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 33 France: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 34 France: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 35 France: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 36 UK: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 37 UK: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 38 UK: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 39 UK: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 40 UK: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 41 Italy: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 42 Italy: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 43 Italy: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 44 Italy: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 45 Italy: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 46 Netherlands: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 47 Netherlands: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 48 Netherlands: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 49 Netherlands: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 50 Netherlands: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 51 Spain: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 52 Spain: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 53 Spain: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 54 Spain: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 55 Spain: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 56 Russia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 57 Russia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 58 Russia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 59 Russia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 60 Russia: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 61 Asia Pacific: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 62 Asia Pacific: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 63 Asia Pacific: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 64 Asia Pacific: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 65 Asia Pacific: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 66 China: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 67 China: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 68 China: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 69 China: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 70 China: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 71 Japan: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 72 Japan: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 73 Japan: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 74 Japan: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 75 Japan: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 76 India: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 77 India: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 78 India: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 79 India: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 80 India: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 81 Indonesia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 82 Indonesia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 83 Indonesia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 84 Indonesia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 85 Indonesia: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 86 Malaysia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 87 Malaysia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 88 Malaysia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 89 Malaysia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 90 Malaysia: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 91 South Korea: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 92 South Korea: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 93 South Korea: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 94 South Korea: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 95 South Korea: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 96 Latin America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 97 Latin America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 98 Latin America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 99 Latin America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 100 Latin America: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 101 Brazil: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 102 Brazil: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 103 Brazil: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 104 Brazil: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 105 Brazil: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 106 Mexico: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 107 Mexico: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 108 Mexico: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 109 Mexico: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 110 Mexico: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 111 Argentina: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 112 Argentina: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 113 Argentina: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 114 Argentina: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 115 Argentina: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 116 Middle East & Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 117 Middle East & Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 118 Middle East & Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 119 Middle East & Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 120 Middle East & Africa: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 121 UAE: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 122 UAE: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 123 UAE: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 124 UAE: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 125 UAE: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 126 Saudi Arabia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 127 Saudi Arabia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 128 Saudi Arabia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 129 Saudi Arabia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 130 Saudi Arabia: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 131 South Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 132 South Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 133 South Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 134 South Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 135 South Africa: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 136 Israel: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 137 Israel: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 138 Israel: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 139 Israel: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 140 Israel: AI in Genomics Market, by Application, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global AI in Genomics Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Offering
  • Figure 7. Global AI in Genomics Market, by Offering, 2021 & 2030 (USD Million)
  • Figure 8. Market by Technology
  • Figure 9. Global AI in Genomics Market, by Technology, 2021 & 2030 (USD Million)
  • Figure 10. Market by Functionality
  • Figure 11. Global AI in Genomics Market, by Functionality, 2021 & 2030 (USD Million)
  • Figure 12. Market by End User
  • Figure 13. Global AI in Genomics Market, by End User, 2021 & 2030 (USD Million)
  • Figure 14. Market by Application
  • Figure 15. Global AI in Genomics Market, by Application, 2021 & 2030 (USD Million)